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Aim: After in vivo implantation of cell-loaded devices, only the cells close to the 
capillaries can obtain nutrients to maintain their functions. It is known that factors 
secreted by stem cells, rather than stem cells themselves, are fundamental to guarantee 
new vascularization in the area of implant. Materials & methods: To investigate 
this possibility, we have grafted mice with Bilayer and Flowable Integra® scaffolds, 
loaded or not with human adipose-derived stem cells. Results: Our results support 
the therapeutic potential of human adipose-derived stem cells to induce new vascular 
networks of engineered organs and tissues. Conclusion: This finding suggests that our 
approach can help to form new vascular networks that allow sufficient vascularization 
of engineered organs and tissues in cases of difficult wound healing due to ischemic 
conditions.
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It is widely accepted that tissue engineering 
and regenerative medicine are on the front 
line as potentially ideal approaches for the 
treatment of diseases as well as the repair of 
damaged tissues and organs [1]. Neverthe-
less, crucial obstacles persist for a wide appli-
cation of these approaches. For example, 
after the in vivo implantation of cell-loaded 
devices, only the cells within a distance of 
100–200 µm to the nearest capillaries obtain 
a sufficient supply of oxygen and nutrients 
to maintain their metabolism and functions, 
while the cells in the core of the device are 
destined to die. This is more valid for large 
scaffolds where cell survival is largely ham-
pered by the limited diffusion of oxygen and 
nutrients [2]. Supplying neovascularization 
could partially overcome these problems. 
New vessel formation can be enhanced by 
designing instructive materials, in other 
words, materials capable to impart instruc-
tions to cells with the aim of guiding their 
fate [3], containing angiogenic growth factors 
or by the inclusion of endothelial cells [1,4]. 
In particular, endothelial progenitor cells are 
good candidates for vascularization in tissue 
engineering, as they are able to differentiate 
into mature endothelial cells both in vitro 
and in vivo [2,5–6].
The majority of materials and cell 
types screened so far in tissue engineer-
ing approaches have shown limited clini-
cal relevance, due to the insufficient num-
ber of obtainable endothelial cells or to 
the use of animal-derived matrices [3,7]. 
Ingram et al. [8] identified a number and a 
hierarchy of endothelial progenitor cells in 
the vessel wall, providing a new framework 
for classification of cells supporting endopoi-
esis akin to that previously established for 
hematopoiesis. Endothelia may be derived 
from various sources including mesenchy-
mal stem cells, also known as mesenchymal 
stromal cells (MSCs), a heterogeneous pop-
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ulation of multipotent adult stem cells of mesodermal 
origin. The principal source of MSCs is the adipose 
tissue from human adults, which is easily accessible 
in large quantities with minimal invasive harvest-
ing procedure. A subset of the MSC fraction consists 
of the so-called adipose-derived stem cells (ASCs) 
that contains a high amount of stem cells, essential 
requirement for stem-cell-based therapies and tissue 
engineering [9]. MSCs have a variety of roles in tissue 
vascularization, both through direct contact and indi-
rect signaling. Within this frame, it has been postu-
lated that MSCs (and ASCs in particular) are a subset 
of pericytes or vascular stem/precursor cells at vari-
ous stages of differentiation, located in the wall sur-
rounding the vasculature [10]. It has also been hypoth-
esized that, in virtually all organs and tissues, blood 
vessels harbor ubiquitous MSCs in their perivascular 
niche [11].
Biomaterial-induced auto-regeneration of func-
tional tissues is based on the temporary substitution 
with an implanted material that will be later replaced 
by functional tissue [1,12]. During this time, which 
is characterized by cell growth, differentiation, inva-
sion and angiogenesis, it is fundamental to ensure 
the presence of factors derived from MSCs rather 
than the MSCs themselves [13]. These secreted fac-
tors, mostly proteins, include numerous enzymes, 
growth factors, cytokines and hormones or other 
soluble mediators that are fundamental for regu-
lating cell-to-cell and cell-to-extracellular matrix 
interactions [14].
To investigate the possibility to induce the angio-
genetic process, we have grafted athymic CD-1® nude 
male mice with collagen scaffolds (Integra® bilayer 
and Flowable Wound Matrix) loaded or not with 
human ASCs (hASCs). In clinical setting, the bilayer 
scaffold is commonly used for the management of 
ulcers and wounds, including the surgical or chronic 
wounds and burn reconstruction; instead, the Flow-
able Wound Matrix is more indicated in the case of 
a ‘tunnel’ wound into deep soft tissue characterized 
by an irregular geometry, when is necessary to fill the 
wound and achieve a contact with the wound bed, we 
have found that hASCs can induce potent vascular-
ization of both supercharged scaffolds. This finding 
lets us to conclude that our approach could be used 
in situations where wound healing is difficult or even 
impossible because of ischemic condition.
Materials & methods
All protocols were reviewed and approved by the ‘Uni-
versity of Insubria’ and ‘Ospedale di Circolo Fondazi-
one Macchi’ ethic committees in accordance with the 
Declaration of Helsinki.
Patient samples
The adipose tissue were obtained, after the informed 
consensus, by surgical intervention of female subjects 
(n = 5), due to breast hypertrophy (gigantomastia). 
Their ages ranged from 21 to 58 years (mean ± standard 
deviation [SD]: 33.4 ± 5.3 years) and their BMI from 
18.8 to 27.2 kg/m2 (mean ± SD: 25.6 ± 2.6 kg/m2). All 
donors were in good health, had no history of diabetes 
or metabolic disorders, and were not receiving medica-
tions at the time of surgery. Gigantomastia allowed us 
to get large amount of adipose tissue from the same 
depot. Furthermore, the severe selection of the patients, 
young and healthy women who have not undergone 
to heavy weight loss diet, guaranteed adipose tissue of 
good quality rich hASCs which are characterized by 
low immunogenicity.
Animals
4-week-old athymic CD1 nude mice (Crl:CD1-
Foxn1nu086) were obtained from Charles River (Calco, 
LC, Italy).
The animal studies were conducted at the Univer-
sity of Insubria following international and national 
rules for animal care, and approved by the local Ethi-
cal Committee (Comitato Etico per la Sperimentazi-
one Animale). In total, 25 animals have been used for 
experimental purposes.
Materials
Integra bilayer and Flowable Wound Matrix were 
kindly provided and characterized by LifeSciences 
Corporation (Plainsboro, NJ, USA). The bilayer scaf-
fold is an advanced wound care device comprised of 
porous matrix of crosslinked bovine tendon collagen, 
glycosaminoglycan and a semi-permeable polysiloxane 
layer. The meshed bilayer allows drainage of wound 
exudate and provides a flexible adherent covering for 
the wound surface. The collagen-glycosaminoglycan 
biodegradable matrix provides a scaffold for cellular 
invasion and capillary growth [15].
Scaffold compatibility & cell viability
Integra bilayer was incubated in petri dish supple-
mented with culture medium (see below) for 24 h at 
37°C in order to test its compatibility with hASCs. 
Petri dish was then observed by an inverted phase-
contrast microscope Zeiss Axiovert 200 (Arese, MI, 
Italy) connected to an AxioCam ICm1camera (Zeiss); 
photographs were acquired by the Axiovision Rel 4.8 
software (Zeiss).
Cell viability was determined by the RealTime-
Glo™ MT assay (Promega, Milano, Italy) according 
to the manufacturer’s instructions. Briefly, 200 µl of 
hASCs suspension (containing about 1 × 103 cells) 
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were seeded, together with the scaffold and the assay 
reagent, into 24-well assay plates and cultivated for 
6 days at 37°C in 5% of CO
2
. Every 24 h lumines-
cent signal has been recorded using the Infinite F200 
plate reader (Tecan Group, Männedorf, Switzerland). 
The experiments were performed in triplicate and nor-
malized compared with cell viability in absence of the 
scaffold. For all the experiments we have used hASCs 
at the passage 5.
hASCs isolation & culture
hASCs were isolated from human mammary adi-
pose tissue after surgical intervention due to breast 
hypertrophy (gigantomastia). The stromal cellular 
fraction, obtained according to Gronthos and Zan-
nettino protocol [16], was seeded in flask and main-
tained in 15 ml of complete 1:1 DMEM/DMEM-
F12 medium containing 10% fetal bovine serum, 
2–4 mM L-Glu, 1% penicillin/streptomycin, 0.1% 
gentamicin and 0.5 mg fungizone. After 6 h, non 
attached cells were removed and adherent cells were 
fed with fresh medium.
hASCs characterization by FACS analysis
Cell surface phenotype was assessed by immuno-
fluorescence and cytofluorimetric analysis using a 
FACSAria II apparatus (BD, NJ, USA) and a series 
of monoclonal antibodies (mAb) specific for nomi-
nal staminal markers CD44, CD90, CD105, for 
the differentiation marker CD45 and for major his-
tocompatibility molecules including HLA class I 
(HLA-A,B,C) and class II (HLA-DR). Anti-CD44, 
-CD45, -CD105 mAbs were fluorescein isothiocya-
nate labeled while anti-CD90 was PE labeled. Anti-
HLA class I and class II mAbs were unlabeled and 
revealed by a second-step incubation with fluorescein 
isothiocyanate-labeled goat antimouse Ig. After anti-
body staining, cells were washed with PBS at 4°C and 
Figure 1. Xenogenic grafting of bilayer and flowable Integra® scaffolds. (A) Photograph of the mouse posterior 
side. White arrows point to the position of Integra bilayer scaffold injections with (bottom) or without (upper) 
ASCs; black arrows point to the position of flowable Integra scaffold injection with (right) or without (left) ASCs. 
(B) Grafting of 1 × 1 cm2 Integra bilayer scaffold in the lower back side of the mouse used for this experiment. 
(C) Position tracks and mice after injection of flowable Integra scaffolds. (D) Grafting of the flowable Integra 
scaffold in the left dorsum of the mice used for this experiment.  
ASC: Adipose-derived stem cell.
Integra in sheet
without ASCs
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fixed with 150 µl of PBS 4% paraformaldehyde for 
30 min before cytofluorimetric analysis.
hASCs differentiation
Xenogenic grafting
Integra bilayer scaffold (1 × 1 cm2) was left in culture 
medium for 24 h at 37°C and 5% CO
2
. Then, 3 × 105 
ASCs were seeded onto the scaffold and maintained for 
24 h before the grafting into the mice, pretreated with 
intraperitoneal injection of 60 mg/kg of ketamine and 
5 mg/kg of midazolam. The grafting was accomplished 
by an incision of 1.5 cm in the lower backside of the 
mouse between muscle and subcutaneous layer. The 
control scaffold was grafted in the upper backside. The 
incision was sutured by a 4/0 polyamide monofilament 
nonabsorbable suture (Figure 1A & B).
The flowable Integra was grafted between muscle and 
subcutaneous layer into the left dorsum of mice by a 
syringe with a luor-lock connector. The injection system 
consisted of two separate syringes, one containing 1 ml 
of flowable Integra, and one containing 1 ml the ASC 
suspension (3 × 106); as control, 1 ml of flowable Integra 
and 1 ml of culture medium was used. A total volume of 
200 µl was injected into the right backside of each animal 
(Figure 1C & D). The incision was sutured by a 4/0 poly-
amide monofilament as described above. During the first 
3 days after the surgical procedure, a daily subcutaneous 
injection of carprofen (4 mg/kg) was performed.
Macroscopic & microscopic scaffold analysis 
after animal sacrifice
After 30 days from the grafting, mice were sacrificed in 
a CO
2
 chamber. The scaffold and the newly formed tis-
sue specimens were harvested along with the attached 
skin. After gross observation by circular lens (Canon 
EOS 550 D) and image capture, the samples were fixed 
in 10% neutralized formalin solution, dehydrated with 
ethanol (70, 90, 95, 100%), then embedded in paraf-
fin and sectioned. In order to analyze the newly formed 
tissue, some slices were stained with H&E solution fol-
lowing classical procedures. Induction of vasculariza-
tion was evaluated by counting the number of capil-
laries present in the microscope field of three H&E 
stained tissue samples for each injected animal.
The presence of hASC was investigated by immu-
nohistochemistry using MAB 1287, against a human 
small nuclear ribonucleoprotein, and MAB 1273, an 
antihuman mitochondrial antigen. Briefly, sections were 
immersed twice in xylene, rehydrated with a series of 
ethanol (95, 90, 70, 50, 30%), washed with distilled 





 (Bio-Optica, Milano, Italy). The 
antigen retrieval was performed with 0.05% trypsin in 
a wet chamber at 37°C and 15 min. The sections were 
incubated, at room temperature, with 100 µl of 1:200 
diluted primary antibody (MAB 1273 or MAB 1287) 
in a wet chamber for 1 h, rinsed twice, incubated with 
100 µl of appropriately diluted biotinylated second-
ary antibody for 30 min, rinsed twice, and incubated 
with 100 µl appropriately diluted HRP Streptavidin 
(Bio-Optica) for 30 min. After washing, the color was 
revealed by incubation with freshly made DAB solu-
tion (Bio-Optica). Slides were counterstained with 30% 
hematoxylin to visualize nuclei for 4 min, washed with 
distilled water and dehydrated with ethanol (70, 90, 95, 
100%), placed in xylene and mounted using Eukitt (Bio-
Optica). The sections were then observed by an optic 
microscope Aristoplan (Leica Microsystems, Milano, 
Italy) equipped with a Nikon Coolpix 5400 camera.
Scanning electron microscopy analysis
Samples were fixed in 1% Karnowsky solution in 
0.1 M sodium cacodylate buffer (pH 7.4) for 6 h at 
4°C and preserved in the same buffer. The speci-
mens were dehydrated in graded ethanol and dried in 
hexamethyl disilazane (Sigma-Aldrich, Milano, Italy), 
Figure 2. Compatibility test of the scaffold. (A) Picture, 
acquired by a camera connected to an inverted  
phase-contrast microscope, shows the presence of 
living cells seeded onto the Integra® bilayer and 
maintained in culture for 24 h. Arrows indicate cells in 
mitosis. (B) Cell viability of hASCs cultured in presence 
or not of Integra for 144 h. 
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mounted on aluminium stubs, then covered with 8 nm 
of gold (Emitech K550) and observed with a Philips 
SEM-FEG XL-30 (Eindhoven, The Netherlands). The 
scaffold and the newly formed tissue specimens were 
harvested along with the attached skin.
RNA extraction, retrotranscription  
& real-time PCR
Total RNA was isolated using the ReliaPrepTM FFPE 
(Promega) according to the protocol. The extracted 
RNA was quantified by the QuantiFluor® RNA System 
(Promega) and then retrotranscribed by the iScriptTM 
cDNA Synthesis Kit (Bio-Rad, Segrate, Italy) accord-
ing to the manufacturer’s instructions. The generated 
cDNA was stored at -20°C.
The quantitative real-time PCR was performed by 
iTaq™ Universal SYBR® Green Supermix (Bio-Rad) 
technology using CFX Connect™ Real-Time PCR 
Detection System apparatus (Bio-Rad). Specific prim-
ers were designed by Beacon Designer Program (Bio-
Rad). Mouse β-Actin was used as endogenous control 
gene whereas Cd105, Cd31 and Cd34 as angiogenetic 
markers (Table 1).
PCR reaction contained 5 µl of SYBR Green Super-
mix (2×), 0.5 µl of primers mix (6 µM), 75 ng of cDNA 
and nuclease-free water to a total volume of 10 µl.
Thermocycler program included an initial hot start 
cycle at 95°C for 3 min followed by 50 amplification 
cycles consisting of a denaturation step at 95°C for 10 s 
and an extension phase at 60°C for 30 s. The tempera-
ture was raised from 65°C to 95°C, at 0.5°C/5 s, for 
Melt-curve analysis. For all samples, reactions were 
performed in triplicate.
Comparative cycle threshold (ΔCt) method was used 
to normalize gene-expression levels among control and 
target genes. Results are expressed as mean ± SD.
Results
Scaffold characterization & biocompatibility
Bilayer and flowable Integra have been made by Life-
Sciences Corporation. Information about the structure 
and porosity characteristics are available at Integra web 
site [15]. As shown in Figure 2, the hASCs seeded on to 
the scaffold can survive and proliferate.
hASC characterization
To assess the phenotype of in vitro isolated ASCs, mor-
phology and cell surface markers were investigated. 
By phase contrast microscopy, the cells displayed a 
spindle-shaped aspect with fibroblast-like morphol-
ogy (Figure 3, bottom panel). They grew attached to 
the culture plates and these characteristics were well 
preserved also after seeding on to the scaffold as high-
lighted in Figure 2. By immunofluorescence and cyto-
fluorimetric analysis (Figure 3, histograms in the upper 
panel), ASCs expressed MSC markers such as CD44, 
CD90 and CD105, but not CD45, a cell surface mole-
cule expressed on endothelium as well as on leukocytes. 
ASCs expressed HLA class I but not HLA class II (DR) 
cell surface molecules. Of notice, cell surface expres-
sion of CD44, CD90, CD105 and HLA class I mark-
ers was a characteristic of the entire ASC population, 
thus operationally defining the homogeneity of the 
cells under study.
Macroscopic scaffold analysis after animal 
sacrifice
Scaffolds injected with hASC were surgically implanted 
into immunodeficient CD1 mice as described in the 
‘Materials & Methods’ section. 30 days after surgery 
the animals were sacrificed, the engrafted scaffolds 
removed and analyzed. Upon macroscopic inspection 
of both flowable and bilayer scaffolds, clear differences 
Table 1. Primers used in this work.
Gene name Sequence 5´–3´ Tm (°C) NCBI accession number 
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were seen between the systems loaded or not with hASCs 
(Figure 4). In particular, as shown in Figure 4A–C, vas-
cularization did not occur in cell-free scaffolds, either 
bilayer or flowable. Conversely, in bilayer and flowable 
hASCs-enriched scaffolds (Figure 4D–G), the vascu-
larization was evident. Note that the vascularization 
developed in a centripetal mode and branched within 
the scaffold, (Figure 4F & G). Moreover, after removal 
from the animal, the flowable ASCs system appeared 
yellow and soft on palpation. These characteristics 
have been observed for all the examined scaffolds.
Microscopic scaffold analysis after animal 
sacrifice
To confirm that new vascularization, as well as fresh 
connective tissue, have been successfully induced 
only in the hASCs Integra system, all the scaffolds, 
removed 1 month after grafting, were subjected to 
microscopic observation (representative photographs 
are reported in Figure 5). A simple H&E staining 
clearly showed the total absence of vascularization in 
the scaffold not loaded with hASCs (Figure 5A); con-
versely, numerous cell nuclei (probably of fibroblasts) 
and capillaries (full of erythrocytes) were present 
in the scaffold loaded with hASCs (Figure 5B). The 
immunohistochemistry, performed using MAB 1273 
and MAB 1287, markers of human cells and human 
stem cells respectively, showed no positive reaction 
(Figure 5C & D). After immunohistochemistry, the 
same slides were counterstained with hematoxilin to 
relieve the presence of some nuclei. Also in this case, 
histological analysis of the Integra cell free system 
showed only the presence of rare connective tissue cells 
and the total absence of vascularization (Figure 5C). 
Conversely, similar analysis of the hASCs Integra 
system highlighted the presence of new connective 
Figure 3. Cell surface phenotype and morphology of primary adipose-derived stem cells. Cell surface phenotype 
of primary adipose-derived stem cells was assessed by immunofluorescence and flow cytometry. (A) The various 
cell surface markers listed in the top of each histogram were assessed by using specific monoclonal antibodies 
either directly labeled with fluorochromes (fluorescein isothiocyanate-labeled anti-CD44, anti-CD45,  
anti-CD105 or PE-labeled anti-CD90), or unlabeled (anti-HLA-A, B, C and anti-HLA-DR) and revealed by a second 
step incubation with fluorescein isothiocyanate-labeled rabbit antimouse IgG. Specific fluorescence is represented 
by the bold histogram; negative isotype control is represented by the dashed histogram. Values are expressed 
in the abscissa as mean fluorescence in au and in the ordinate as number of cells analyzed. (B) Cell morphology 
of adipose-derived stem cell is shown in as assessed by inverted phase-contrast microscopy. The cells present a 
spindle-shaped aspect with fibroblast-like morphology. 
au: Arbitrary unit.
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tissue, including the adipose tissue, and several capil-
laries containing erythrocytes (Figure 5D). The quan-
titative evaluation of Cd105, Cd31 and Cd34 mRNA 
strengthens the undeniable vascularization process in 
mice that were grafted with Integra-hASCs system 
(Figure 6). The number of vessels ranged from 2 to 
13/mm2, depending of their diameter, with a mean 
of 5 ± 2.5 without significant differences between the 
two types of scaffolds.
Scanning electron microscopy, performed 1 month 
after grafting, showed the presence of newly formed 
connective tissue (Figure 5E) and cells inside the scaf-
fold. Cell colonization was represented by numerous 
rounded or ovoidal cells (Figure 5F). Tissue necrosis, 
cyst formation or fibrosis were not observed. For brev-
ity, figures refer only to the results obtained on flow-
able scaffold, but the same outcomes have been seen in 
the Integra bilayer system.
Figure 4. Representative macroscopic scaffold analysis after animal sacrifice. (A) In toto bilayer and (B) flowable 
cell-free scaffold. The vascularization is absent. (C) Cell-free flowable scaffold, sectioned, after removal from the 
animal show that the vascularization is completely absent. In toto bilayer and flowable adipose-derived stem 
cell-enriched scaffolds (D & E), the neo-vessel component, developed in centripetal mode and branched within 
the scaffold, is evident (arrow). (E) Flowable adipose-derived stem cells system, sectioned after removal from mice 
shows the presence of vascularization. (F) Enlargement of panel (E). (G) The scaffold appears yellow and soft on 
palpation, the neo-vessel component is clearly developed inside (arrow).
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Figure 5. Microscopic analysis of scaffolds removed 1 month after grafting. Microphotograph in (A) is a 
representative photograph of Integra® cell free system stained with hematoxylin and eosin: note the presence of 
collagen fibers and absence of vascularization. (B) is a representative photograph of Integra-adipose-derived stem 
cells system stained with hematoxylin and eosin: numerous cell nuclei (probably of fibroblasts) and capillaries 
(full of erythrocytes) were present. (C & D) show the immunohistochemistry analysis of Integra cell loaded system 
using the antibodies MAB 1287, against the human small nuclear ribonucleoprotein, and MAB 1273, an antihuman 
mitochondrial antigen stained with DAB and counterstained with hematoxylin. No signal for the presence of 
human cells was detected. In (C), note the presence of newly formed collagen fibers and several adipocytes (bold 
arrows). In (D), in addition to collagen fibers, note the presence of several fibroblast nuclei (thin arrows) and new 
vessels, which contain erythrocytes (arrowheads). (E) shows a scanning electron microscopy picture where newly 
formed collagen fibrils are evident. In (F), a cell, covered by some new formed collagen fibrils, appears to have 
colonized the scaffold.
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Discussion
Soft tissue reconstruction is a challenge for regenerative 
medicine. Stem cell transplantation approaches have 
acquired increasing interest in this direction although 
the mechanisms by which stem cells of various origin 
actually operate as promoters and/or generators of new 
tissues are still poorly understood.
In this study, we investigated one fundamental 
aspect of tissue reconstruction related to the possibility 
that hASCs may promote neo-vascularization in vivo 
of a collagen scaffold implanted in immunodeficient 
mice and thus favor the correct microenvironment for 
neo-tissue generation.
The novelty of our approach resides in the simultane-
ous graft of two different scaffolds (Integra bilayer and 
Flowable Wound Matrix) loaded or not with hASCs, 
in the same animal. We demonstrated that, indeed, 
hASCs could recruit cells able to form new connective 
tissue (loose and adipose) and enhance the vascularity 
inside the grafted scaffold. Adult adipose tissue is one 
of the largest and most plastic tissues in the body and 
it is well recognized as a source of hormones, cytokines 
as well as the main reservoir of energy. These character-
istics contribute in rendering the adipose tissue one of 
the most highly vascularized tissues in the body [17]. In 
adipose tissue, a very close anatomical and physiologi-
cal relationship has been demonstrated between blood 
vessels, perivascular cells and the hASCs [18]. It has 
been reported that hASCs are capable of dividing and 
renewing for extended periods of time both in vitro and 
in vivo [19,20], moreover, in vitro they have the capability 
of differentiating into many different cell types, such as 
osteoblasts, chondrocytes, myocytes, neuronal-like cells, 
cardiovascular cells, hepatocytes and adipocytes [21]. 
Furthermore, a single hASC can undergo clonal expan-
sion while maintaining multilineage differentiation 
potential. Indeed, our hASC population maintains the 
expression of adipose stem cell markers, while lacking 
markers of mature endothelium. Interestingly, hASCs 
express substantial amounts of HLA class I cell surface 
molecules, which are directly involved in the early criti-
cal events of human lymphocyte activation and prolif-
eration [22] and may be expressed at low level in other 
pluripotent stem cells. Conversely, our hASCs do not 
express antigen-presenting cell surface HLA class II 
(DR) molecules, which are the most potent inducers of 
immune rejection responses in human and mouse trans-
plantation. This could be an advantage for the poten-
tial use of hASCs in human tissue reconstruction, in 
particular when heterologous transplant is necessary.
Among the several animal models introduced in the 
last years to study the hASCs in vivo, nude mice have 
the advantages of accepting xenogeneic transplants 
and having a limited cost. Thus, they are amenable to 
repeatable controlled experimentation. In our in vivo 
study, athymic CD1 nude mice have been grafted with 
two different collagen–chondroitin sulphate scaffolds 
(bilayer and flowable Integra) already used in recon-
structive daily surgery. The flowable is more indicated 
in deep defect where a 3D reconstruction is needed, 
while the laminar is used for superficial defects where 
the dermal layer is missing. Collagen and chondroitin 
sulphate, used in scaffold formulation, have shown high 
biocompatibility, both in vitro and in vivo. Further-
more, collagen, in addition to being the most diffuse 
protein in the human body, is crucial in extracellular 
matrix organization, and for its potential of being vas-
cularized, a fundamental step for the success of tissue 
reconstruction. Our results demonstrate that the com-
bined use of hASCs and scaffold can result in a newly 
induced vascularization (Figures 4–6). At macroscopic 
level, the hASC-seeded scaffolds, removed 30 days after 
the graft, showed a structured and ordered diffusion of 
neo-angiogenesis toward a centripetal vascular orienta-
tion, as the new blood vessels were stimulated to grow 
inside of the tridimensional scaffold. At microscopic 
level, hemathoxylin staining of the hASC-Integra sys-
tem highlighted the presence, within the scaffold, of 
fibroblasts, unilocular adipose tissue and vessels con-
taining erythrocytes; this last observation has been 
also confirmed by Cd105, Cd31 and Cd34 mRNA 
expression in the hASC-Integra system. The immu-
nohistochemistry analysis has excluded the presence of 
human cells above and within the hASC-Integra sys-
tem suggesting that the hASCs seeded onto the scaf-
fold were not survived. Scanning electron microscopy 
analysis further substantiated the presence of newly 
formed collagen fibrils, probably induced by the pres-
ence of hASCs as observed in vitro by Tsuji et al. [23]. 
All together, these results, suggest that hASCs are 
Figure 6. Expression of Cd105, Cd31 and Cd34 in mice 
grafted with human adipose-derived stem  
cells-enriched or cell-free scaffold system. Cytoplasmic 
βActin has been used as reference gene. 
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able to create a kind of Stem Bag system [24] inside the 
collagen scaffold, capable to release grow factors and 
cytokines to establish the correct microenvironment to 
attract new cells from the host tissue and support their 
differentiation during tissue regeneration.
All the characteristics just described were absent in 
the scaffolds not charged with hASCs. Another interest-
ing aspect is that no difference was observed between 
the laminar and the flowable scaffold in their potential 
to generate neo-angiogenesis and new tissues in presence 
of hASCs. Thus, we may conclude that both scaffolds 
can be used in association with hASCs to successfully 
induce new vascularization and tissue regeneration.
Several studies reported the transfection of the 
hASCs to induce controlled differentiation and incre-
ment of growth factors secretion [19,25]. However, stem 
cells transfection is a major manipulation and, in a 
therapeutic prospective, it should be taken into con-
sideration that in several countries the law forbids such 
major cell manipulations.
The capacity of inducing neovascularization in a para-
crine fashion and the relatively short lifespan of hASCs 
are both crucial elements to favor their use in clinical 
settings [26]. Indeed, on one side, hASCs can provide 
the necessary physiological elements and microenviron-
ment promoting neo-vascularization and, on the other 
side, their rapid disappearance might prevent a possible 
neoplastic transformation.
We think that this is another step ahead in the stem 
cells therapy, especially when the principal aim is not 
the direct differentiation of the staminal cells, but their 
use to promote the new tissue reconstruction by the cells 
already present in the host organism.
Conclusion
In conclusion, the results of this work strongly support 
the therapeutic potential of using hASCs, to form new 
vascular networks that allow sufficient vascularization 
of engineered organs and tissues. The principal source of 
hASCs is the adipose tissue from human adults, which 
is easily accessible in large quantities with minimal inva-
sive harvesting procedure and provides higher amount 






instruments  availability.  Riccardo Balzaretti  is  a  PhD  student 
of  the  Biotechnology,  Biosciences  and  Surgical  Technology 
course at Università degli studi dell’Insubria.







subject matter or materials discussed in the manuscript.
No writing assistance was utilized in the production of this 
manuscript.




Characteristics of human adipose mesenchymal stem cells
•	 Previous works have suggested that mammary adipose tissue, obtained after a gigantomastia intervention, 
is the best source to get human adipose-derived stem cells (hASCs) in comparison to abdominal, inguinal or 
thigh adipose tissue.
•	 hASC characterization has indicated that more than 90% of the population expressed stem cell markers.
•	 hASC seeded on to the scaffold can survive and proliferate in vitro for at least 6 days.
Grafting procedure
•	 Simultaneous graft of two different scaffolds (Integra® bilayer and Flowable Wound Matrix) loaded or not 
with hASCs, has been performed in the same animal.
In vivo performances of the scaffold adipose-derived stem cell system
•	 Both flowable and bilayer scaffolds hASCs enriched induce new vascularization and connective tissue.
•	 The immunohistochemistry, performed using markers of human cells and human stem cells, showed no 
positive reaction indicating that after 30 days the hASCs are no longer present.
•	 These results were confirmed both by macroscopic and microscopic analysis.
Conclusion
•	 The principal aim of the scaffold adipose-derived stem cells system is not the survival and differentiation 
of the staminal cells, but to promote the new tissue reconstruction by the cells already present in the host 
organism.
•	 The capacity of inducing neovascularization in a paracrine fashion and the relatively short lifespan of hASCs 
are both crucial elements to favor their use in clinical settings.
www.futuremedicine.com 271future science group
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